Skip to Main Content

+

  • • Associated with profound hypercalcemia

++

Epidemiology

+

  • • Found in 0.5-1% of patients with hyperparathyroidism

    • Cancer is palpable in 50% of the patients

    • 5% of parathyroid cancers are nonfunctional

    • Patients with parathyroid cancer are on average younger at the time of diagnosis than patients with benign hyperparathyroidism

    • Equal distribution among men and women

++

Symptoms and Signs

+

  • • Palpable neck mass

    • Hoarseness

    • Fatigue, depression, nausea, vomiting, dehydration, polydipsia, polyuria

    • Pathologic fractures

    • Nephrolithiasis (70% of patients)

    • Nephrocalcinosis

    • Severe renal dysfunction (20-50% of patients)

    • Pancreatitis and peptic ulceration (10-15% of patients)

++

Laboratory Findings

+

  • • Profound hypercalcemia

    • Elevated intact parathyroid hormone (PTH)

+

  • • Parathyroid carcinoma is suspected at operation if parathyroid is hard, whitish, has an irregular capsule, or is invasive

    • Rarely diagnosed preoperatively

+

  • • Physical exam

    • PTH and calcium levels

    • Chest and neck CT scan

+

  • • Anecdotal evidence for role of radiation therapy in local control of disease

++

Surgery

+

  • • Surgical resection is mainstay of treatment

    • En bloc resection should be carried out where possible (including ipsilateral thyroid lobe and central compartment lymph nodes)

    • Resection of local recurrent or metastatic disease is recommended if possible

++

Indications

+

  • • All parathyroid carcinomas should be resected

++

Radiation

+

  • • Anecdotal evidence for role of radiation therapy in local control of disease

++

Medications

+

  • • Palliative drug: IV bisphosphonate to maintain eucalcemia

++

Treatment Monitoring

+

  • • Physical exam

    • Serum calcium and intact PTH levels

++

Prognosis

+

  • • Indolent malignancy, with local and distant metastases occurring over many years

    • 5-year survival rates range from 40% to 69%

++

References

Shattuck TM et al: Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003;349:1722.  [PubMed: 14585940]

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.